Negotiated Medicare drug prices take effect for the first 10 drugs under the Inflation Reduction Act

Negotiated prices for the first 10 Medicare Part D drugs take effect: Eliquis (−67%), Jardiance (−66%), Xarelto (−62%), Januvia (−79%), Farxiga (−68%), Entresto (−73%), Enbrel (−67%), Imbruvica (−38%), Stelara (−66%), and insulin products (−75%). Medicare beneficiaries immediately save $1.5B+ annually at the pharmacy. It's the first time in Medicare history that negotiated drug prices have taken effect.